The Artificial Heart: Medical Improvements on Infections and Strokes

  • Lavatharshan Aramboo McGill University


Artificial hearts are designed to eliminate the need for heart transplants. However, these devices are prone to creating complications such as infections or strokes. The complications occur from the mechanical aspects of the device. Therefore, the devices’ effectiveness is influenced by their design. This paper provides an overview of the different artificial hearts that are currently being researched. Three devices are investigated: the total artificial heart, the left ventricular assist device, and the total internal artificial heart. Reviewing research shows that the total artificial heart may result in both infections and strokes.  The left ventricular assist device lowered the probability of these complications but did not eliminate the risk altogether. While the internal artificial heart was able to eliminate the risk of infections entirely, it introduced new complications.  Given these results, artificial hearts still require further research to improve upon the smaller technical aspects.

Author Biography

Lavatharshan Aramboo, McGill University

B.Eng Mechanical Engineering

Minor in Biomedical Engineering


Cohn, W. E., Timms, D. L., & Frazier, O. (2015). Total artificial hearts: past, present, and future. Nature Reviews Cardiology.

DeVries, W. C. (1988). The permanent artificial heart: Four case reports. JAMA: Journal of the American Medical Association, 259(6), 849. Retrieved from

Fox, C. S., McKenna, K. L., Allaire, P. E., Mentzer, R. M., & Throckmorton, A. L. (2015). Total Artificial Hearts—Past, Current, and Future. Journal of Cardiac Surgery, 30(11), 856-864.

From, R. P., Hasan, D., Froehler, M. T., & Goerbig-Campbell, J. L. (2013). Stroke and Left Ventricular Assist Device (LVAD). Open Journal of Anesthesiology, 03(01), 51-56. doi:10.4236/ojanes.2013.31014

Gray Jr, N. A., & Selzman, C. H. (2006). Current status of the total artificial heart. American Heart Journal, 152(1), 4-10. doi:

Griffith, B. P., Hardesty, R. L., Kormos, R. L., Trento, A., Borovetz, H. S., Thompson, M. E., & Bahnson, H. T. (1987). Temporary Use of the Jarvik-7 Total Artificial Heart before Transplantation. New England Journal of Medicine, 316(3), 130-134. doi:doi:10.1056/NEJM198701153160303

Hajar, R. (2007). The artificial heart (Vol. 8).

Khan, S., & Jehangir, W. (2014). Evolution of Artificial Hearts: An Overview and History. Cardiology Research, 5(5), 121-125.

Rose, E. A., Moskowitz, A. J., Packer, M., Sollano, J. A., Williams, D. L., Tierney, A. R., . . . Gelijns, A. C. (1999). The REMATCH trial: rationale, design, and end points. The Annals of Thoracic Surgery, 67(3), 723-730. doi:

Samak, M., Fatullayev, J., Sabashnikov, A., Zeriouh, M., Rahmanian, P. B., Choi, Y.-H., . . . Ruhparwar, A. (2015). Past and present of total artificial heart therapy: a success story. Medical Science Monitor Basic Research, 21, 183.

Travis, A. R., Giridharan, G. A., Pantalos, G. M., Dowling, R. D., Prabhu, S. D., Slaughter, M. S., . . . Koenig, S. C. (2007). Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery, 133(2), 517-524. doi:

Zareba, K. M. (2002). The artificial heart--past, present, and future. Medical Science Monitor Basic Research, 8(3), RA72-RA77.